Tonix Pharmaceuticals Announces Data Supporting the Memory- and Cognition-Enhancing Effects of Racemic Tianeptine and (S)-Tianeptine, but not -Tianeptine, in the In Vivo Rat Novel Object Recognition Test

CHATHAM - Tonix Pharmaceuticals Holding Corp. , a biopharmaceutical company, today announced data supporting the memory- and cognition-enhancing effects of two Tonix drug candidates, TNX-601 ER and...

Related Keywords

Russia ,United States ,Chatham ,Maryland ,France ,French ,America ,Jessica Morris ,Seth Lederman ,Gregory Sullivan ,Nasdaq ,Tonix Pharmaceuticals Holding Corp ,Exchange Commission ,Tonix Pharmaceuticals ,French Transparency Committee ,Tonix Research ,Development Center ,Pharmaceuticals Holding ,Novel Object Recognition ,Chief Executive Officer ,Chief Medical Officer ,Novel Object Recognition Test ,Recognition Index ,Private Securities Litigation Reform Act ,Annual Report ,News Publishing ,